MicroRNAs, innate immunity and ventricular rupture in human myocardial infarction

Nina Zidar1, Emanuela Boštjančič, Damjan Glavač

  • 1Institute of Pathology, University of Ljubljana, Slovenia. nina.zidar@mf.uni-lj.si

Disease Markers
|November 4, 2011
PubMed

Insights

Altered microRNA expression, including miR-146a, miR-150, and miR-155, is linked to myocardial infarction (MI) and ventricular rupture (VR). These microRNAs regulate innate immunity, suggesting a role in post-MI inflammation and VR pathogenesis.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Immunology

Background:

  • MicroRNAs (miRNAs) are key post-transcriptional regulators of gene expression.
  • Innate immunity activation and inflammation are critical after myocardial infarction (MI).
  • Intense inflammation post-MI may contribute to ventricular rupture (VR).

Purpose of the Study:

  • To investigate the expression of specific microRNAs (miR-146a, miR-150, miR-155) in myocardial infarction (MI).
  • To compare microRNA expression between MI patients with and without ventricular rupture (VR).
  • To explore the role of these microRNAs in innate immunity and VR pathogenesis.

Main Methods:

  • Real-time PCR was used to analyze miRNA expression.
  • Autopsy samples of infarcted heart tissue from 50 MI patients were studied.
  • Patients were categorized into groups with and without VR.

Main Results:

  • All three studied microRNAs (miR-146a, miR-150, miR-155) showed altered expression in MI compared to normal hearts.
  • MI patients with VR exhibited up-regulation of miR-146a.
  • MI patients with VR showed down-regulation of miR-150 and miR-155 compared to those without VR.

Conclusions:

  • Altered expression of miR-146a, miR-150, and miR-155 occurs in MI.
  • These miRNAs are involved in innate immunity regulation.
  • Differential expression patterns in VR patients suggest a role in VR pathogenesis via inflammation.